Patents
Patents for C07D 513 - Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups , or (15,120)
04/2008
04/01/2008US7351821 Oxabispidine compounds useful in the treatment of cardiac arrhythmias
04/01/2008US7351732 Serotonin (5-hydroxytriptamine, 5-HT) 5-HT1A receptor subtype agonists; neuroprotective agents; cerebral damage due to traumatic or ischemic stroke; 2-[4-[(Chroman-2-yl)methylamine]butyl]-1,3-dioxoperhydropyrrolo[1,2-c]imidazol
04/01/2008US7351712 Inhibitors of the FAK (focal adhesion kinase) protein tyrosine kinases, antiproliferative, antitumor; for example 5-{4-[(1-Hydroxy-cyclopentylmethyl)-amino]-5-trifluoromethyl-pyrimidin-2-ylamino}-1,3-dihydro-indol-2-one
04/01/2008US7351481 electrical stability, better charge transporting capability, a high glass transition temperature, and does not crystallize; high-efficiency, low-voltage, high-luminance, long-lifespan; durability; color purity
04/01/2008CA2298974C Thiazolobenzoheterocycles, preparation and medicines containing same
03/2008
03/27/2008WO2008036420A2 9-(heteroaryl)-isothiazolo[5,4-b]quinoline-3,4-diones and related compounds as anti-infective agents
03/27/2008WO2008036272A1 HETEROCYCLIC INHIBITORS OF c-MET AND USES THEREOF
03/27/2008WO2008034863A2 Sulfonylpyrazoline carboxamidine derivatives as 5-ht6 antagonists
03/27/2008WO2008011560A3 Benzothiophene inhibitors of rho kinase
03/27/2008WO2007117381A9 2 -aminopyridine analogs as glucokinase activators
03/27/2008WO2007092879A3 Substituted thiatriazaacenaphthylene-6-carbonitrile kinase inhibitors
03/27/2008US20080076917 Intermediates of 2-Substituted Carbapenem Derivatives and Process for Production Thereof
03/27/2008US20080076809 Heterocyclic compound for stimulating or inducing the growth of the hair or eyelashes and/or slowing down their loss composition comprising it and its uses
03/27/2008US20080076773 Such as (3R,4R)-1-Pyrimidin-4-yl-4-(2,4,5-trifluorophenyl)piperidin-3-amine bis-trifluoroacetic acid salt
03/27/2008CA2663528A1 Heterocyclic inhibitors of c-met and uses thereof
03/27/2008CA2662484A1 Sulfonylpyrazole and sulfonylpyrazoline carboxamidine derivatives as 5-ht6 antagonists
03/26/2008EP1902025A1 Kinase inhibitors
03/26/2008EP1901731A1 Niacin receptor agonists, compositions containing such compounds and methods of treatment
03/26/2008CN100376572C Anti-infective agents
03/26/2008CN100376569C Inhibitors of farnesyl protein transferase
03/25/2008US7348326 in brain; (2,5-difluorodifluorophenyl)-N-methyl-N-((1-propylbenzimidazol-2-yl)methyl)carboxamide; anxiolitic and antidepressant; finding and altering the signal-transducing activity of gamma aminobutyric acid (GABA) receptors; detectably-labeled antagonist/agonist of GABAR
03/20/2008WO2008015137A3 Substituted indanyl sulfonamide compounds, their preparation and use as medicaments
03/20/2008WO2007103250A3 Thiadiazole compounds and their use in phototherapy
03/20/2008WO2007084391A3 Thiazole compounds as protein kinase b ( pkb) inhibitors
03/20/2008US20080070943 Sulfonyldihydroimidazopyridinone compounds as 5-hydroxytryptamine-6 ligands
03/19/2008EP1899357A1 Pyrido-thiazinium dyes
03/19/2008CN101146889A Luminous compound containing lanthanide ion
03/19/2008CN101146811A Hiv整合酶抑制剂 Hiv integrase inhibitors
03/19/2008CN101146807A Process for preparing 2-methyl-1-(2-methylpropyl)-1H-imidazo[4,5-C][1,5]naphthyridin-4-amine
03/18/2008US7345178 Sirtuin modulating compounds
03/18/2008US7345069 Oxidative activation and episulfonium ion-mediated DNA alkylation-based anticancer
03/18/2008US7345055 2,7-dimethylimidazo[1,2- alpha ]pyridin-3-ylmethyl)-dimethylamine; nitric oxide synthase inhibitor; neurodegenerative diseases and antiinflammatory, antitumor agent; multiple sclerosis, Parkinson's, Alzheimer's or Huntington's disease, cerebral ischemia, diabetes, meningitis, angiogenesis,
03/13/2008WO2007148185A3 Substituted 3 -amino- pyrrolidino-4 -lactams as dpp inhibitors
03/12/2008CN101142212A 2-phenoxy-n-(1,3,4-thiadizol-2-yl)pyridin-3-amine derivatives and related compounds as p2y1 receptor inhibitors for the treatment of thromboembolic disorders
03/12/2008CN101139340A N-(substituted arylmethyl)-4-(disubstituted methyl)piperidines and piperazines
03/12/2008CN100374435C Substd. pyridines and pyridazines with angiogenesis inhibiting activity
03/11/2008US7342034 Fused heterocyclic compounds and analogs thereof, modulators of nuclear hormone receptor function
03/11/2008US7342014 Diamine derivatives
03/11/2008US7342012 Inhibitors of αLβ2 mediated cell adhesion
03/11/2008US7342011 Rifamycin analogs and uses thereof
03/11/2008US7342010 2-thiaquinolizidines and process for the preparation thereof
03/06/2008WO2008025170A1 Selective glycosidase inhibitors and uses thereof
03/06/2008WO2007146813A3 Pyridinone analogs as cell proliferation inhibitors
03/06/2008US20080058395 Fused heterocyclic inhibitors of D-amino acid oxidase
03/06/2008US20080058319 Fused ring heterocycles as potassium channel modulators
03/06/2008CA2661582A1 Selective glycosidase inhibitors and uses thereof
03/05/2008EP1894920A1 Pharmaceutical composition comprising azarhodacyanine compound as active ingredient
03/05/2008EP1893599A1 Compounds for the treatment of multi-drug resistant bacterial infections
03/05/2008EP1383733B1 Process for the preparation of 1,3-substituted indenes and aryl-fused azapolycyclic compounds
03/05/2008CN101137661A Imidazothiazole derivative and method for producing same
03/05/2008CN101137660A Benzothiazole, thiazolopyridine, benzooxazole and oxazolopyridine derivatives as antidiabetic compounds
03/05/2008CN100372848C Spiroazacyclic compounds as monoamine receptor modulators
02/2008
02/28/2008WO2008023066A1 Imidazole compounds having an antiinflammatory effect
02/28/2008WO2008009700A8 Derivatives and analogs of n-ethylquinolones and n-ethylazaquinolones
02/28/2008WO2007147575A3 Substituted sulfonamido-macrocycles as tie2 inhibitors and salts thereof, pharmaceutical compositions comprisings same, methods of preparing same and uses same
02/28/2008CA2660957A1 2-phenoxy pyrimidinone analogues
02/28/2008CA2660951A1 Haloalkyl-substituted pyrimidinone derivatives
02/27/2008EP1891077A1 Monomers , oligomers and polymers of thieno (3, 4-d) thiazole
02/27/2008CN101133034A Substituted indazolyl sulfonamide and 2,3-dihydro-indolyl sulfonamide compounds, their preparation and use in medicaments
02/21/2008WO2008021491A2 Method for synthesis of 8-alkoxy-9h-isothiazolo[5,4-b]quinoline-3,4-diones
02/21/2008WO2007136746A3 Macrocyclic compounds and their uses as stearoyl-coa desaturase
02/21/2008US20080045524 Selective NPY (Y5) antagonists
02/21/2008US20080045514 3-Aryl-6-aryl-7H-[1,2,4]triazolo[3,4-b][1,3,4]thiadiazines and analogs as activators of caspases and inducers of apoptosis and the use thereof
02/21/2008US20080045503 Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
02/21/2008CA2695072A1 Method for synthesis of 8-alkoxy-9h-isothiazolo[5,4-b]quinoline-3,4-diones
02/20/2008EP1888575A2 Compounds for modulating trpv3 function
02/20/2008CN100369919C Tricyclic protein kinase inhibitors
02/20/2008CN100369912C Heteroaryl substituted fused bicyclic heteroaryl compounds as GABAA receptor ligands
02/19/2008US7332487 Nitrogen-containing 5-membered ring compound
02/19/2008CA2481723C 5ht2c receptor modulators
02/14/2008WO2008019096A1 Processes for the preparation of n-(2-acetyl-4,6-dimethylphenyl)-3-{[(3,4 dimethyl-5-isoxazolyl)amino}sulfonyl}-2-thiophenecarboxamide
02/14/2008WO2008019074A1 Processes for the preparation of 4-chloro-3-methyl-5-(2-(2-(6-methylbenzo[d][1,3]dioxol-5-yl)acetyl)-3-thienylsulfonamido) isoxazole
02/14/2008WO2008017688A1 2-carboxy thiophene derivatives as anti-viral agents
02/14/2008WO2008017161A1 Azacycloalkane derivatives as inhibitors of stearoyl-coenzyme a delta-9 desaturase
02/14/2008WO2007117381A3 2 -aminopyridine analogs as glucokinase activators
02/14/2008US20080039629 Benzothniazole compositions and their use as ubiquition ligation inhibitors
02/14/2008US20080039482 Sulfonamido-macrocycles as tie2 inhibitors and salts thereof, pharmaceutical compositions comprising same, methods of preparing same and uses of same
02/14/2008US20080039456 4-[2-(4-nitro-phenyl)-6-oxo-4-thioxo-6H-1-oxa-3b,5-diaza-cyclopenta[a]pentalen-5-yl]-butyric acid, used for inhibiting heparin-binding proteins and in the treatment of pancreatic cancer; anticarcinogenic agents
02/14/2008US20080039449 [1,4]benzodiazepine derivatives, used for treating osteoarthritis, pancreatitis, glomerulonephritis, rheumatoid arthritis, inflammatory bowel disease, Crohn's disease, psoriasis, graft vs host disease, leukemia, septic shock, multiple sclerosis, and inflammatory bowel disease
02/14/2008CA2660114A1 Azacycloalkane derivatives as inhibitors of stearoyl-coenzyme a delta-9 desaturase
02/14/2008CA2659884A1 Processes for the preparation of n-(2-acetyl-4,6-dimethylphenyl)-3-{[(3,4 dimethyl-5-isoxazolyl)amino}sulfonyl}-2-thiophenecarboxamide
02/13/2008EP1887007A2 Novel compounds
02/13/2008EP1885720A2 4-(thiazol-2-ylthioalkyl)-pyrazoles and their use as herbicides
02/13/2008EP1678175B1 Medical use of zwitterionic compounds being cftr channel modulators
02/13/2008EP1638951B1 Cyclohexyl sulphones as gamma-secretase inhibitors
02/13/2008EP1463716B1 Pyrrolidine and piperidine derivates as nk1 antagonists
02/13/2008EP1044189B1 Aryl fused azapolycyclic compounds
02/12/2008US7329756 Process for the manufacture of Isradipine
02/12/2008US7329683 Moderation of cortisol; non-insulin dependent diabetes; hypotensive agents; using a 1,2,4 triazole compound
02/12/2008US7329682 Method for inhibiting 5-lipoxygenase using a benzoxazole derivative
02/12/2008US7329677 2-[3-(4-Methoxypyridin-2-yl)prop-2-yl]-3H-imidazo[4,5-b]pyridine hydrochloride; transcriptional activation of the iNOS-promoter, tissue and organ damage, cytotoxicity reduction
02/07/2008WO2008016288A1 Benzimidazo[1,2-c][1,2,3]thiadiazol-7-sulfonamides as inhibitors of carbonic anhydrase and the intermediates for production thereof
02/07/2008WO2008015340A2 Pyrazolo[4,3-d]thiazole derivatives, and preparation and therapuetic application thereof
02/07/2008WO2008015137A2 Substituted indanyl sulfonamide compounds, their preparation and use as medicaments
02/07/2008WO2007140385A3 Thiazole compounds as cannabinoid receptor ligands and uses thereof
02/07/2008US20080032999 viricides for treating a hepatitis C virus infection
02/07/2008US20080032996 Substituted Quinazoline or Pyridopyrimidine Derivative
02/07/2008CA2659581A1 Substituted indanyl sulfonamide compounds, their preparation and use as medicaments
02/06/2008EP1884515A1 Substituted indanyl sulfonamide compounds, their preparation and use as medicaments
02/06/2008CN101120005A Thiazolopyrimidine compounds for the modulation of chemokine receptor activity
1 ... 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 ... 152